Who is sponsoring NCT05044481?

NCT05044481 is sponsored by Hospital Carlos Van Buren.

What drugs are being tested in NCT05044481?

Interventions in NCT05044481: third molar surgical removal.

What condition does NCT05044481 study?

NCT05044481 studies Health-related Quality of Life, Third Molar.

Is NCT05044481 still recruiting?

NCT05044481 is currently completed. Last updated 14 September 2021.

Last reviewed 2021-09-14 · How we verify

NCT05044481

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

"Impact of the Third Molars in Oral Health-related Quality of Life"

Completed Last updated 14 September 2021

What this trial tests

trial testing third molar surgical removal in Health-related Quality of Life in 70 participants. Completed in 14 June 2020.

Timeline

5 February 2019

Primary endpoint
3 March 2020

14 June 2020

Quick facts

Lead sponsor	Hospital Carlos Van Buren
Status	Completed
Study type	OBSERVATIONAL
Enrollment	70
Start date	5 February 2019
Primary completion	3 March 2020
Estimated completion	14 June 2020
Sites	1 location across Chile

Drugs / interventions tested

third molar surgical removal

Conditions studied

Health-related Quality of Life — all drugs for Health-related Quality of Life →
Third Molar — all drugs for Third Molar →

Sponsor

Hospital Carlos Van Buren

Who can join

18 and older, any sex, with Health-related Quality of Life or Third Molar. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the impact of the third molars in oral health-related quality of life, before and after surgical removal using a validated and frequently used in international investigations instrument (OHIP-14).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Health-related Quality of Life

Currently open trials in the same condition.

NCT06754722 — Decentralized Clinical Trial of Effectiveness of EnergyPoints App in Cancer Survivors · NA · recruiting
NCT07241325 — Psychological Well-Being, Depression, and Health-Related Quality of Life in Adults With Type 2 Diabetes: A Cross-Section · recruiting
NCT06579950 — Assessing the Effects of Cool Roofs on Indoor Environments and Health · NA · recruiting
NCT06490393 — The Impact of Supervision by a Health Care Professional on Quality of Life Questionnaire · recruiting

Other Hospital Carlos Van Buren trials

Trials by the same sponsor.

NCT04863170 — Cross Cultural Adaptation and Validation of Orthognathic Quality of Life Questionnaire (OQLQ) · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05044481 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hospital Carlos Van Buren
Last refreshed: 14 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05044481.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing